Recurrent hypoglycaemic episodes in a patient with Type 2 diabetes under fibrate therapy

Journal of Diabetes and its Complications

Volumn 16, Issue 3, 2002, Pages 246-248

  Klein, Johannes ^a   Ott, Volker ^a   Schütt, Morten ^a   Klein, Hans H ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Fibrate; Hypertriglyceridaemia; Hypoglycaemia; Insulin resistance

Indexed keywords

ALLOPURINOL; BUDESONIDE; CERIVASTATIN; DIGITOXIN; FIBRIC ACID DERIVATIVE; FUROSEMIDE; GEMFIBROZIL; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IPRATROPIUM BROMIDE; LOSARTAN; METOPROLOL; OMEPRAZOLE; PHENPROCOUMON;

AGED; ARTICLE; BLOOD CHEMISTRY; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CASE REPORT; CLINICAL FEATURE; DIET; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTILIPEMIC AGENTS; DIABETES MELLITUS, TYPE 2; FEMALE; GEMFIBROZIL; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 0036107614     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(01)00186-6     Document Type: Article

References (19)

1. The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients. For the Gemfibrozil Study Group
2. Hypertriglyceridemia: Cause or consequence of insulin resistance?
3. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
4. Pathogenesis of Type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes
5. Insulin resistance and cardiovascular disease
6. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome
7. Iprofibrate effects on carbohydrate and lipid metabolism in Type 2 diabetes mellitus subjects
8. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes
9. Hypertriglyceridemia and insulin resistance
10. Gemfibrozil treatment of hypertriglyceridemia: Improvement on fibrinolysis without change of insulin resistance
11. Gemfibrozil treatment of endogenous hypertriglyceridemia: Effect on insulin-mediated glucose disposal and plasma insulin concentrations
12. Obesity and insulin resistance
13. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids
14. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency
15. Effects of gemfibrozil on insulin and on haemostatic variables in hypertriglyceridemic patients
16. Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: A putative role for Randle's cycle in its pathogenesis?
17. Development of insulin resistance in the JCR:LA-cp rat: Role of triacylglycerols and effects of MEDICA 16
18. Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia
19. Does familial hypertriglyceridemia predispose to NIDDM?